Effects of low molecular weight heparin and fondaparinux on mortality, hemorrhagic and thrombotic complications in COVID-19 patients

BACKGROUND: Coronavirus disease 2019 (COVID-19) is associated with increased thrombosis prevalence. However, there are insufficient data supporting the appropriate anticoagulation dose in COVID-19. OBJECTIVE: We aim to systematically assess the currently available data regarding the effects of diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Fragkou, Paraskevi C., Palaiodimou, Lina, Stefanou, Maria Ioanna, Katsanos, Aristeidis H., Lambadiari, Vaia, Paraskevis, Dimitrios, Andreadou, Elisabeth, Dimopoulou, Dimitra, Zompola, Christina, Ferentinos, Panagiotis, Vassilakopoulos, Theodoros I., Kotanidou, Anastasia, Sfikakis, Petros P., Tsiodras, Sotirios, Tsivgoulis, Georgios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Neurology in the Time of COVID-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136435/
https://www.ncbi.nlm.nih.gov/pubmed/35646159
http://dx.doi.org/10.1177/17562864221099472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136435/
https://www.ncbi.nlm.nih.gov/pubmed/35646159
http://dx.doi.org/10.1177/17562864221099472

Ejemplares similares